204 related articles for article (PubMed ID: 37715207)
21. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
Deng T; Zhang L; Shi Y; Bai G; Pan Y; Shen A; Han X; Yang Z; Chen M; Zhou H; Luo Y; Zheng S; Ba Y
Invest New Drugs; 2023 Dec; 41(6):808-815. PubMed ID: 37889382
[TBL] [Abstract][Full Text] [Related]
23. Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.
Balasubramanian B; Yacqub-Usman K; Venkatraman S; Myint KZ; Juengsamarn J; Sarkhampee P; Lertsawatvicha N; Sripa J; Kuakpaetoon T; Suriyonplengsaeng C; Wongprasert K; Grabowska AM; Bates DO; Janvilisri T; Tohtong R
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173994
[TBL] [Abstract][Full Text] [Related]
24. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
Feng L; Xie Y; Zhang H; Wu Y
Med Oncol; 2012 Jun; 29(2):856-63. PubMed ID: 21264532
[TBL] [Abstract][Full Text] [Related]
25. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
26. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
Wen D; Li S; Ji F; Cao H; Jiang W; Zhu J; Fang X
Tumour Biol; 2013 Apr; 34(2):793-803. PubMed ID: 23296701
[TBL] [Abstract][Full Text] [Related]
27. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Zhang L; Dong Y; Zhu N; Tsoi H; Zhao Z; Wu CW; Wang K; Zheng S; Ng SS; Chan FK; Sung JJ; Yu J
Mol Cancer; 2014 May; 13():124. PubMed ID: 24885920
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.
Chen ZR; Chueh CH; Chiang NJ; Tsai YW
Cost Eff Resour Alloc; 2023 Sep; 21(1):61. PubMed ID: 37697368
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
31. Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations.
Lindley A; Prager G; Bitzer M; Burn TC; Lihou CF; Croft E
Cancer Res Treat; 2024 Feb; ():. PubMed ID: 38351684
[TBL] [Abstract][Full Text] [Related]
32. microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6.
Chen H; Cheng C; Gao S
Biochem Biophys Res Commun; 2020 Sep; 530(3):566-573. PubMed ID: 32747087
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
[TBL] [Abstract][Full Text] [Related]
34. A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer.
Wang F; Fan M; Zhou X; Yu Y; Cai Y; Wu H; Zhang Y; Liu J; Huang S; He N; Hu Z; Ding G; Jin X
J Exp Clin Cancer Res; 2021 Jan; 40(1):44. PubMed ID: 33499877
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.
Kouhkan F; Mobarra N; Soufi-Zomorrod M; Keramati F; Hosseini Rad SM; Fathi-Roudsari M; Tavakoli R; Hajarizadeh A; Ziaei S; Lahmi R; Hanif H; Soleimani M
J Med Genet; 2016 Jan; 53(1):24-33. PubMed ID: 26510428
[TBL] [Abstract][Full Text] [Related]
36. Caudatin induces cell apoptosis in gastric cancer cells through modulation of Wnt/β-catenin signaling.
Li X; Zhang X; Liu X; Tan Z; Yang C; Ding X; Hu X; Zhou J; Xiang S; Zhou C; Zhang J
Oncol Rep; 2013 Aug; 30(2):677-84. PubMed ID: 23708208
[TBL] [Abstract][Full Text] [Related]
37. Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.
Shi GM; Huang XY; Wen TF; Song TQ; Kuang M; Mou HB; Bao LQ; Zhao HT; Zhao H; Feng XL; Zhang BX; Peng T; Zhang YB; Li XC; Yu HS; Cao Y; Liu LX; Zhang T; Wang WL; Ran JH; Liu YB; Gong W; Chen MX; Cao L; Luo Y; Wang Y; Zhou H; Yang GH; Fan J; Zhou J
Cancer Med; 2023 Feb; 12(4):4137-4146. PubMed ID: 36127767
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
39. miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma.
Wei LJ; Li JA; Bai DM; Song Y
Chem Biol Interact; 2018 Jun; 289():9-14. PubMed ID: 29660302
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
